Latest Impairment News

Marimaca Copper Corp. has issued a prospectus for a nominal cleansing offer of 100 new CDIs at A$10.65 each, aiming to remove trading restrictions on previously issued securities. The company also disclosed extensive risk factors, including ongoing legal proceedings and project development uncertainties.

South32 warns of an impending impairment expense linked to uncertain electricity supply for its Mozal Aluminium smelter, with FY26 production guidance now under review amid ongoing tariff negotiations.

Jatcorp anticipates a significant net loss for FY2025 driven by halted sales in China and legal disputes, yet remains cautiously optimistic about growth prospects in FY2026.

ECS Botanics is supplying its Avani THC10 capsules to a University of Western Australia clinical trial exploring medicinal cannabis as a treatment for obstructive sleep apnoea. The study aims to shed light on THC’s impact on sleep quality and cognitive function.

Tourism Holdings Limited trims its FY25 profit guidance to the lower end of analyst expectations, citing ongoing challenges in global RV sales and a potential goodwill impairment tied to its US operations.

Collins Foods Limited has confirmed its FY25 earnings aligned closely with market forecasts, addressing ASX concerns over potential surprises. The company highlighted positive margin outcomes and clarified the impact of a Netherlands impairment.

Brickworks Limited reports a mixed second half of FY25 with strong property gains offset by a significant impairment in its North American operations, while its planned merger with Soul Patts remains on track.

Aurizon updates its FY2025 EBITDA guidance to approximately $1.575 billion, reflecting volume and receivables adjustments, while announcing a strategic leadership restructure to unify Bulk and Containerised Freight operations.

Kip McGrath Education Centres announces exit from its unprofitable USA operations while reporting improved underlying EBITDA for FY25, alongside CEO transition costs and property lease provisions.

Collins Foods delivered resilient FY25 results with solid revenue growth and a strategic pivot towards German market expansion, while addressing profitability challenges in the Netherlands.

Collins Foods reported a record $1.52 billion revenue for FY25 with flat EBITDA despite tough market conditions, while signaling optimism for low to mid-teens NPAT growth in FY26.

Collins Foods Limited reported record revenue of $1.52 billion for FY25, up 2.1%, but statutory net profit plunged 88.5% due to significant impairments and wage provisions. The company declared a fully franked final dividend of 15 cents per share, signaling confidence despite challenges.